Autoimmune Diabetes Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Autoimmune Diabetes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Evaluation of Oxidative Stress: Comparison Between Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults

Type 1 Diabetes MellitusLatent Autoimmune Diabetes in Adult (LADA)
Fondazione IRCCS Policlinico San Matteo di Pavia75 enrolled1 locationNCT07434154
Recruiting
Phase 2

Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years

Diabetes MellitusType 1 DiabetesDiabetes type1+1 more
Massachusetts General Hospital100 enrolled1 locationNCT05866536
Recruiting
Phase 2

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

Diabetes Mellitus, Type 1Diabetes type1Autoimmune Diabetes
Massachusetts General Hospital150 enrolled1 locationNCT05180591
Recruiting
Not Applicable

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

PancreatitisType 1 Diabetes (T1D)Latent Autoimmune Diabetes in Adult (LADA)
Yale University60 enrolled1 locationNCT06967701
Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Autoimmune HepatitisSystemic Lupus ErythematosusHemophagocytic Lymphohistiocytoses+17 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled1 locationNCT04902807
Recruiting
Not Applicable

Intensive Dietary and Activity Counselling (IDAC)

Type 1 DiabetesAutoimmune Diabetes
Lund University800 enrolled1 locationNCT06670625
Recruiting

Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)

Type 1 DiabetesDiabetic Kidney DiseaseDiabetic Nephropathies+2 more
University of Colorado, Denver100 enrolled1 locationNCT05319990